From casual to cultured, the iMerit blog tackles a wide array of topics related to security, expertise, and flexibility in the Artificial Intelligence and Machine Learning data-enrichment marketplace.
Oct 10, 2025
In 2022, the global autonomous vehicle (AV) market was valued at USD 1.5 trillion. By 2030, it is projected to
Aug 13, 2025
How Foundation Models Are Transforming Pathology AI Foundation models are reshaping how we think about medical data labelling and training.
Aug 13, 2025
Radiology is leading the charge in medical AI, with startups and healthcare providers racing to build FDA-cleared tools for early
Aug 13, 2025
As AI systems grow more powerful and embedded in real-world decisions, model evaluation becomes just as important as training. Today’s
Aug 13, 2025
If you’re building AI for tumor detection, biomarker quantification, or cell-level segmentation, choosing the right annotation partner and tooling platform
Aug 13, 2025
Building an AI model that can generate coherent content is one thing. Building one that performs to expert standards is
Aug 13, 2025
When human annotators disagree, it raises a critical question: how can we trust an AI model trained on that data?
Aug 8, 2025
Training perception systems for autonomous vehicles, robotics, and drones requires more than just labeling images or point clouds in isolation.
Aug 8, 2025
3D point cloud annotation is no longer a niche task; it’s a mission-critical process powering perception systems in autonomous vehicles,
Aug 8, 2025
In high-stakes data labeling environments, whether it’s annotating video for autonomous vehicles or segmenting medical images, the clear and consistent
Aug 6, 2025
As pharmaceutical and biotech companies increasingly adopt AI for clinical trial optimization, treatment response evaluation, and post-market surveillance, one critical
Aug 6, 2025
Large language models (LLMs) have revolutionized AI applications, yet their raw outputs miss the nuanced judgment humans expect. Reinforcement Learning
Aug 4, 2025
Explore how iMerit helps pharma and life sciences teams overcome data fragmentation, regulatory hurdles, and multimodal annotation challenges to build clinical-grade AI. From adverse drug reactions to biomarker discovery, see real-world examples of scalable, traceable AI workflows.